혈관 현미경 시장 예측(2025-2030년)

The Angioscope Device Market is expected to grow from USD 200.138 million in 2025 to USD 240.209 million in 2030, at a CAGR of 3.72%.

The global angioscope device market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases and an aging population. Angioscopes, used to examine the interior of blood vessels, enable direct visualization of vascular abnormalities, thrombus composition, and atherosclerosis staging. Unlike angiography, angioscopy is more invasive but provides critical insights for diagnosing and treating vascular diseases, particularly in cardiovascular care. The technology supports onsite bypass processes and informs optimal treatment strategies, enhancing patient outcomes.

Market Growth Drivers

The primary drivers include the increasing incidence of heart diseases, growing demand for minimally invasive procedures, and the rise in stent surgeries. The aging global population further amplifies the need for advanced diagnostic tools like angioscopes. Strategic collaborations among industry players are expanding product portfolios to meet the demand for non-invasive and patient-friendly solutions. For instance, partnerships between companies like ACIST Medical Systems, Inc. and Medis Medical Imaging are enhancing market reach and innovation in North America, driving adoption of angioscope technologies.

Market Segmentation Analysis

The angioscope device market is segmented by end-user and geography. By end-user, the market includes hospitals, ambulatory centers, and research facilities. Hospitals dominate due to increased investments in healthcare infrastructure and the growing need for advanced medical equipment to address cardiovascular diseases. The rise in hospital construction globally, supported by government initiatives to improve healthcare facilities, is boosting demand for angioscopes. Ambulatory centers are also gaining traction as minimally invasive procedures become more prevalent, while research facilities benefit from increased funding for vascular studies.

Technological Advancements and Research

Rising investments in research and development are propelling market growth. Ongoing advancements in angioscope technology are improving diagnostic accuracy and expanding applications. Increased expenditure on radiography and vascular research is driving demand for innovative angioscope devices, as researchers explore new ways to diagnose and manage cardiovascular conditions.

Geographical Outlook

North America is expected to hold a significant market share, driven by the high prevalence of cardiovascular diseases and robust healthcare infrastructure. Government initiatives, such as Canada's USD5 million investment in 2023 to support the Canadian Heart Function Alliance, aim to enhance heart failure diagnosis and treatment, further boosting demand for angioscopes. The Asia Pacific region is projected to experience rapid growth, fueled by increasing healthcare investments and rising cardiovascular disease rates in populous countries like China and India. Europe also shows strong potential, supported by advanced medical research and infrastructure development.

Market Outlook

The angioscope device market is poised for robust expansion through 2030, driven by technological advancements, strategic collaborations, and growing healthcare investments. North America's dominance and Asia Pacific's rapid growth highlight significant regional opportunities. Challenges, such as the invasive nature of angioscopy, are being addressed through innovations aimed at improving patient comfort and diagnostic precision, ensuring sustained market momentum.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Angioscope Device Market Segmentation:

By Component

• Image Fibrescope
• Lensing system
• Delivery Catheter
• Others

By Angioscopy Type

• Occlusion
• Non-Occlusion

By End-User

• Hospitals and Clinics
• Research Institutes
• Diagnostic Centers

By Geography

• North America
• South America
• Europe
• Middle East and Africa
• Asia Pacific

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ANGIOSCOPE DEVICE MARKET BY COMPONENT

• 5.1. Introduction
• 5.2. Image Fibrescope
• 5.3. Lensing system
• 5.4. Delivery Catheter
• 5.5. Others

6. GLOBAL ANGIOSCOPE DEVICE MARKET BY ANGIOSCOPY TYPE

• 6.1. Introduction
• 6.2. Occlusion
• 6.3. Non-Occlusion

7. GLOBAL ANGIOSCOPE DEVICE MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals and Clinics
• 7.3. Research Institutes
• 7.4. Diagnostic Centers

8. GLOBAL ANGIOSCOPE DEVICE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Component
  • 8.2.2. By Angioscope Type
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Component
  • 8.3.2. By Angioscope Type
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Component
  • 8.4.2. By Angioscope Type
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Component
  • 8.5.2. By Angioscope Type
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Component
  • 8.6.2. By Angioscope Type
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Taiwan
    • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Olympus Corporation
• 10.2. Boston Scientific Corporation
• 10.3. LeMaitre Vascular, Inc.
• 10.4. FiberTech Co., Ltd.
• 10.5. VerAvanti, Inc.
• 10.6. Stryker Corporation
• 10.7. Cook Medical

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations